Previous Page  5 / 10 Next Page
Information
Show Menu
Previous Page 5 / 10 Next Page
Page Background

Page 36

conferenceseries

.com

Volume 8

Journal of Palliative Care & Medicine

Hospice 2018

July 18-19, 2018

July 18-19, 2018 Melbourne, Australia

5

th

World Congress on

Hospice and Palliative Care

What is the evidence for early integration of palliative care into the management of serious illness?

Mellar P Davis

Geisinger Medical Center, USA

P

alliative care has emerged as an approach that specifically addresses gaps inherent in a disease-centered approach to

care. Early palliative care has been promoted as the optimal approach to care for individuals with advanced illnesses. A

systematic review of trials found 15 RCTs (Randomized Controlled Trials) of early outpatient, 13 RCTs of home palliative care

and 7 systematic reviews. A subset of RCTs have demonstrated improved symptoms, quality of life, reduced aggressive care at

the end of life, increased advanced directives, reduced hospital stays, improved caregiver burden and quality of life, reduced

costs and improved family satisfaction. Yet RCT have also demonstrated no benefits to palliative care in the same outcomes.

Why the difference? The term “early” and “standard of care” are poorly defined and subject to regional practices. Imbalances

and attrition between groups contributed to differences in outcomes. Many RCTs lacked power calculations or were under

powered for outcome measures. Outcomes were skewed yet parametric statistics were done giving weight to outliers in the

results. Timing of assessment for outcomes in some trials was too early or late to see full benefits. Intention to treat analysis

was often not done; outcomes were based on treatment analysis. Financial assessment was based exclusively on costs or charges

centered on medical resource utilization rather than family expenditures. Multiple models of palliative care were used in these

RCTs. This workshop/concurrent session will review the evidence for early palliative care and the differences and weaknesses

in trials which may have contributed to divergent outcomes.

mdavis2@geisinger.edu

J Palliat Care Med 2018, Volume 8

DOI: 10.4172/2165-7386-C1-015